Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta

The Boost Brittle Bones Before Birth (BOOSTB4) clinical trial is investigating the safety and efficacy of transplanting fetal derived mesenchymal stromal cells (MSCs) prenatally and/or in early postnatal life to treat severe Osteogenesis Imperfecta (OI). This study aimed to explore stakeholder views...

Descripción completa

Detalles Bibliográficos
Autores principales: Hill, Melissa, Lewis, Celine, Riddington, Megan, Crowe, Belinda, DeVile, Catherine, David, Anna L., Semler, Oliver, Westgren, Magnus, Götherström, Cecilia, Chitty, Lyn S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777523/
https://www.ncbi.nlm.nih.gov/pubmed/30918362
http://dx.doi.org/10.1038/s41431-019-0387-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777523/
https://www.ncbi.nlm.nih.gov/pubmed/30918362
http://dx.doi.org/10.1038/s41431-019-0387-4

Ejemplares similares